patients with diabetes have an indefinite need, while weight loss is often viewed as a temporary endeavor
What could that be? In a way, your study found GLP-1s are, at times, working too well
Semaglutide was administered subcutaneously to the subjects once per week at doses that were eventually increased to 1.0 mg
While this is good for weight control, it is also a concern when one has some diseases
While Ozempic remains the primary brand name for semaglutide 0.25mg, 0.5mg, and 1.0mg pre-filled pens, the new approvals provide Novo Nordisk with additional marketing flexibility as nine generic manufacturers prepare to enter the Canadian market
In November 2024, the Ozempic warning label was updated to include pulmonary aspiration during general anesthesia or deep sedation